The clinical evaluation and its results are included or duly referenced in the technical documentation for the device referred to in Article R. 5211-39.
The clinical evaluation and its documentation are updated using data obtained during post-marketing surveillance.
The decision not to conduct clinical follow-up as part of the post-marketing surveillance plan for the device must be duly justified and documented.